Schlumberger to Acquire ChampionX in $7.75B Deal

Global technology company, Schlumberger Limited (NYSE: SLB) announced today that it will acquire ChampionX (Nasdaq: CHX) in an all-stock transaction valued at $7.75 billion. The acquisition comes at an important time in the industry as demand grows for scalable emerging technologies such as AI and autonomous operations across global operations. Under the terms of the… [Read More]

PRISM Market Moves on Tuesday: EXACT Sciences Surges on Colorectal Cancer Test Results; Tesla and Petco Slide

 US equities are down on Tuesday at midday, close to worst levels after stocks finished lower on Monday. Big tech is trading lower with some drag from Tesla ($TSLA) which has declined on weak delivery numbers. Healthcare, semis, apparel retail, software, small-caps, homebuilders, EVs, and airlines are also underperforming. Energy, insurers, copper/aluminum, commodity chemicals, precious… [Read More]

Oil Prices Rise as Middle East Tensions Escalate

Escalating tensions in the Middle East and new targeted Ukrainian drone attacks on Russian energy infrastructure have caused a spike in oil prices, which rose to their highest level since October on Tuesday. On Tuesday, Ukraine struck one of Russia’s largest oil refineries with a drone attack on the highly industrialized Tatarstan region southeast of… [Read More]

NeuroBo Completes Enrollment in Liver Disease Trial

NeuroBo Pharmaceuticals (Nasdaq: NRBO) has completed enrollment of patients in Part 1 of its two-part, Phase 2a clinical trial evaluating the efficacy and safety of DA-1241 for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). Approximately 49 patients with presumed MASH have been randomized into this part of the study. Earlier this month, the company received… [Read More]

Fractyl Health Receives Investigational Device Exemption from FDA for Revita Weight Loss Procedure

Metabolic therapeutics company, Fractyl Health (Nasdaq: GUTS) has received FDA approval of a pivotal Investigational Device Exemption (IDE) to study its lead product candidate, Revita’s, efficacy in maintaining weight loss following the discontinuation of GLP-1 receptor agonist (GLP-1RA) drug therapy, addressing a key unmet need in the treatment of obesity. Revita is an outpatient endoscopic… [Read More]

Amplified Earnings: AmpliTech (AMPG) Announces FY 2023 Earnings

Tech company, AmpliTech Group, Inc. (AMPG) announced its FY2023 financial results and investors seem to find the news positive as the stock is trading upwards of ~15%. Revenues for the year were reported at $15.6M while gross profit margins grew to nearly 47%. While they reported net losses of $2.4M, the company launched over 100… [Read More]

PRISM Market Moves on Monday: Ballard Power Systems Soars; InterDigital and FedEx Fall

US equities are trading lower on Monday afternoon with stocks selling off after finishing higher last week. Underperformers include healthcare, regional banks, homebuilders, trucking, telecoms, credit cards, and drug stores, while semis, precious metals, airlines, energy, hotels/restaurants, dollar stores, casinos, and China tech are stronger. Treasuries are under pressure, the Dollar index is up +0.4%,… [Read More]